Authors: Turgeman, G Pittman, DD Muller, R Kurkalli, BG Zhou, SH Pelled, G Peyser, A Zilberman, Y Moutsatsos, IK Gazit, D

Citation: G. Turgeman et al., Engineered human mesenchymal stem cells: a novel platform for skeletal cell mediated gene therapy, J GENE MED, 3(3), 2001, pp. 240-251

Authors: Varady, P Li, JZ Cunningham, M Beres, EJ Das, S Engh, J Alden, TD Pittman, DD Kerns, KM Kallmes, DF Helm, GA

Citation: P. Varady et al., Morphologic analysis of BMP-9 gene therapy-induced osteogenesis, HUM GENE TH, 12(6), 2001, pp. 697-710

Authors: Helm, GA Li, JZ Alden, TD Hudson, SB Beres, EJ Cunningham, M Mikkelsen, MM Pittman, DD Kerns, KM Kallmes, DF

Citation: Ga. Helm et al., A light and electron microscopic study of ectopic tendon and ligament formation induced by bone morphogenetic protein-13 adenoviral gene therapy, J NEUROSURG, 95(2), 2001, pp. 298-307

Authors: Helm, GA Alden, TD Beres, EJ Hudson, SB Das, S Engh, JA Pittman, DD Kerns, KM Kallmes, DF

Citation: Ga. Helm et al., Use of bone morphogenetic protein-9 gene therapy to induce spinal arthrodesis in the rodent, J NEUROSURG, 92(2), 2000, pp. 191-196

Authors: Alden, TD Pittman, DD Hankins, GR Beres, EJ Engh, JA Das, S Hudson, SB Kerns, KM Kallmes, DF Helm, GA

Citation: Td. Alden et al., In vivo endochondral bone formation using a bone morphogenetic protein 2 adenoviral vector, HUM GENE TH, 10(13), 1999, pp. 2245-2253

Authors: Alden, TD Pittman, DD Beres, EJ Hankins, GR Kallmes, DF Wisotsky, BM Kerns, KM Helm, GA

Citation: Td. Alden et al., Percutaneous spinal fusion using bone morphogenetic protein-2 gene therapy, J NEUROSURG, 90(1), 1999, pp. 109-114